World’s First Use Of FDA-Approved Radiation Therapy To Treat Tumors!

SCIENCE

The Challenge of Cancer

Cancer is a formidable adversary, and finding better ways to combat it is a medical priority. Explore how Stanford Medicine is pioneering a groundbreaking approach to radiation therapy.

A First in the World: SCINTIXTM

Introducing SCINTIXTM, the world's first radiation machine to unite radiotherapy with PET technology. Learn how this innovation targets cancer cells in real-time without harming healthy tissue.

How SCINTIXTM Works

Tracers are injected into the patient's body, adhering to cancer cells and emitting signals that guide the machine to precisely target cancer during radiation treatment.

FDA Approval and Ongoing Research

Tracers are injected into the patient's body, adhering to cancer cells and emitting signals that guide the machine to precisely target cancer during radiation treatment.

Real-Time Precision

Unlike traditional radiation plans, this technology adapts to the dynamic nature of the human body, minimizing harm to healthy tissue.

Benefits for Patients

Unlike traditional radiation plans, this technology adapts to the dynamic nature of the human body, minimizing harm to healthy tissue.

Hope for Advanced Cancer Patients

SCINTIXTM offers hope to individuals with advanced cancer, enabling simultaneous treatment of multiple tumors within the body. Dr. Lucas Vitzthum believes it's a transformative frontier in radiation therapy.

The Future of Cancer Treatment

Stay tuned for the future of cancer treatment, where precision meets hope, thanks to Stanford Medicine's groundbreaking SCINTIXTM technology.